Drug Profile
Eicosapentaenoic acid/docosahexaenoic acid/statin
Alternative Names: Epanova/statin; Fixed dose combination Epanova/statinLatest Information Update: 08 May 2014
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Docosahexaenoic acids; Omega 3 fatty acids; Unsaturated fatty acids
- Mechanism of Action HMG-CoA reductase inhibitors; Triglyceride modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Hypercholesterolaemia; Hypertriglyceridaemia
Most Recent Events
- 06 May 2014 Investigation in Hypercholesterolaemia in United Kingdom (PO)
- 06 May 2014 Investigation in Hypertriglyceridaemia in United Kingdom (PO)